Is @evermore1000 one of us, pethaps?

Good question either way.

@CTV News

Dialysis patients have a high COVID-19 mortality rate, but were left out of vaccine priority: doctors ctvnews.ca/health/coronav…

@evermore1000

Why are they not studying the use of apabetalone for these patients? It has received breakthrough designation from the FDA but a trial has not yet commenced for COVID 19. It seems to hold a lot of promise for heart and kidney patients